AI research on 6 Expansion / Order-win announcements
by Sunita Tools Ltd since July 2026 — deal magnitude, revenue and EPS impact,
execution risk, and the actual return since each announcement measured from the next
trading day's open and benchmarked against the Nifty Smallcap 250.
Deal vs businessOrder book of ₹576 Cr is ~7.5x TTM revenue of ₹77 Cr (Defence backlog alone is ₹552 Cr)
Size vs own revenue7.50× — oversized — in the 90-day study 20% of these fell >25%, against 4% of deals under half of revenue
Execution period3.5 yr
Fundamental gradeB
AI projections
Revenue uplift (yr1 / steady)28.5% / 133.8%
EPS uplift125.0%
Upside base / bull / bear45.0% / 110.0% / -35.0%
Horizon24-36 months
Realized market record
Entry — next-day open (31 Aug 2026)₹1095.0
Latest close (16 Sep 2026)₹967.3
Return since-11.7%
α vs Smallcap 250-8.7%
Positives
Transformational pivot from low-margin tooling to high-value defence engineering (artillery shells, aerospace components).
Consolidated order book of ₹576 Cr provides multi-year revenue visibility (~7.5x TTM revenue).
Strong early traction with 4-month net sales reaching ₹31.95 Cr, showing immediate execution ramp-up.
Strategic capacity additions (2 CNC turning machines) and forward integration via a 90% acquisition in capital goods.
Risks
Mega-order execution risk: Order book to revenue ratio of 7.5x introduces severe working capital, delay, and delivery risks.
Equity dilution risk: Board approval for up to 5 lakh equity shares to fund capex and working capital.
Export regulatory and partner concentration risks in Middle East / NATO supply channels.
Promoter stake declined from 67.71% to 62.75% across recent periods.
Governance flags
Promoter stake dilution/reduction from 67.71% in Oct 2025 to 62.75% in Mar 2026.
Full AI brief
1. Industry Context & Execution Ramp Analysis
Sunita Tools is pivoting from industrial tooling (mould bases, ground plates) into defence manufacturing (155mm M107 artillery shells, precision aerospace machining, and fuses). The private Indian defence manufacturing sector is experiencing structural tailwinds driven by indigenisation mandates (Aatmanirbhar Bharat) and export opportunities to NATO/MENA regions, growing at 25-30% CAGR.
However, precision defence manufacturing is capital-intensive and entails high execution difficulty:
- Stringent quality controls, NATO standard validations, and specialized metallurgy.
- The order book of ₹576 Cr represents ~7.5x TTM revenue (₹77 Cr). As per sound underwriting principles, an order book this large cannot be executed in 12 months. Spreading ₹576 Cr over a realistic 3.5-year delivery window implies annual execution of ~₹150-165 Cr at full ramp.
- Year-1 Ramp: 4-month revenue of ₹31.95 Cr projects an annualized FY27 revenue of ~₹95-100 Cr (+28-30% uplift over TTM ₹77 Cr).
- Steady-State Ramp (FY28-29): Annual revenue can scale toward ₹180 Cr (+134% over TTM ₹77 Cr). At steady-state PAT margins of 15-16%, PAT can rise from ₹11 Cr to ~₹27-29 Cr, lifting EPS from ₹18.60 to ~₹42.00 (post-dilution).
2. Financial Quality & Capital Allocation Assessment
ROCE & Margins: Trailing ROCE stands at 10.5%, reflecting historical legacy tooling operations. Operating margins are healthy at 22.0%, but high working capital requirements in defence orders will constrain cash conversion.
Balance Sheet & Leverage: Debt of ₹43 Cr against Net Worth of ₹70 Cr (D/E of 0.60). The board's decision to raise equity (up to 5 lakh shares) will provide liquidity but dilute existing holders.
Promoter Holding: Stood at 62.75% as of Mar 2026, declining from 67.71% in late 2025.
3. Scenario Analysis
Bull Case (+110%): Flawless execution of M107 shell lines, full conversion of ₹576 Cr order book within 3 years, revenue reaches ₹200+ Cr by FY28 with 16% PAT margin (PAT ₹32 Cr). Multiple stabilizes around 40-45x.
Base Case (+45%): Gradual ramp-up with working capital delays; FY28 revenue reaches ₹150-160 Cr, PAT reaches ₹24 Cr. P/E moderates to ~35-38x on higher earnings base.
Bear Case (-35%): Execution bottlenecks, delays in defence client clearances, cost overruns, and working capital drag; multiple derates toward peer median (~20-25x).
4. Verdict Rationale
The ₹576 Cr order book and 4-month ₹31.95 Cr sales run-rate validate strong commercial traction in defence. However, because order backlog is 7.5x revenue and capital intensity is high, execution and dilution risks temper the verdict to POSSIBLE.
Analysis as of 2026-08-28 (price ₹1076.35) ·
AI research, not investment advice.
On August 11, 2026, Sunita Tools Ltd announced a Board Meeting scheduled for August 14, 2026, to consider raising equity capital. This fundraise is aimed at financing the company's capital expenditure and working capital for its massive transition from legacy tooling to defense manufacturing (Faridabad facility). While equity raises dilute existing shareholders, adequate capital is a prerequisite for executing its ambitious target of expanding artillery shell production capacity from 22,500 units to 130,000+ units and reaching ₹636 Cr revenue by FY29.
2. Ramp-Aware Execution & Catalyst Math
Current Run Rate: TTM Revenue is ₹76 Cr with FY26 Revenue at ₹46.44 Cr. Q1 FY27 net sales jumped 350% YoY to ₹18.64 Cr (~₹75 Cr annualized run-rate).
Capex & Capital Need: Expanding capacity to 130,000–210,000 units requires significant CNC machinery, safety compliance, and testing infrastructure. Debt currently stands at ₹43 Cr against Net Worth of ₹70 Cr (D/E 0.60).
Dilution vs. Growth Math: Assuming a 10-15% equity dilution to raise ~₹60-80 Cr, share count will increase. However, if revenue scales to ~₹200 Cr over 24-36 months with steady-state PAT margins of 16-18%, net profit could reach ₹32-36 Cr (up from ₹12 Cr TTM).
EPS Acceleration: Post-dilution EPS could expand from ₹18.76 TTM to ₹40-45 in a steady-state 3-year horizon.
3. Industry Context & Quality Gate
Industry: Defense Manufacturing / Capital Goods. High capital intensity and strict qualification hurdles.
Industry CAGR: Private defense manufacturing in India is expanding at 25-40% CAGR.
Quality Assessment: Trailing ROCE is modest at 10.5% due to recent capital build-up. Quality gate fails on trailing metrics, but structural earnings potential is high if execution succeeds.
4. Valuation & Risk Calibration
Valuation: Trailing P/E of 52.9x is rich relative to industrial peer median (18.5x), indicating high market expectations are already embedded.
Promoter Stake: Reduction from 67.71% in Oct 2025 to 62.75% in Mar 2026 warrants monitoring.
5. Scenario Analysis & Returns
Bull Case (110% Upside): Seamless execution of M107 shell order book, smooth defense JV ramp-up, FY28 revenue exceeds ₹250 Cr with 18% PAT margin, P/E holds above 35x.
Base Case (35% Upside): Moderate execution delay, revenue reaches ₹180 Cr by FY28, EPS expands to ~₹38 post-dilution, P/E compresses to 30x.
Bear Case (-35% Downside): Qualification delays, severe equity dilution, working capital stress, P/E derates to 20x on missed targets.
6. Verdict Rationale
Sunita Tools is a high-risk, high-reward pivot story. Rated POSSIBLE multibagger with a score of 58/100. Near-term price appreciation will be constrained by equity dilution and high current valuation (52.9x P/E), but the long-term runway in defense manufacturing is substantial if management executes.
Analysis as of 2026-08-11 (price ₹992.30) ·
AI research, not investment advice.
On July 30, 2026, Sunita Tools signed a 5-year non-binding MoU with a Polish defense manufacturer to collaborate on ISR drones and loitering ammunition, proposing a majority-owned Joint Venture (JV) in India.
Year-1 Revenue Uplift:0.0%. Defense JVs require trial prototypes, regulatory clearance, technology transfer, and trial testing before commercial orders materialise.
Steady-State Potential (24-48 Months): If converted into a formal JV and receiving government/GCC export orders, steady-state annual revenue could increase by ~₹15-20 Cr (~20-25% of TTM revenue ₹76 Cr).
Margin Profile: Defense electronics/drones offer OPMs of 25-30%, potentially raising EPS by ~18% once steady-state delivery commences in FY28-FY29.
2. Industry Profile & Quality Check
Capital Intensity:HIGH. Transitioning into aerospace components, artillery shells, and drones requires substantial machinery capex and long working-capital gestation.
Execution Complexity:HIGH. Precision weaponry and unmanned aerial vehicles involve stringent military standards, export controls, and testing.
Fundamental Quality: Moderate. Trailing ROCE is 10.5%, D/E is 0.60, and Net Worth stands at ₹70 Cr. Quality gate is not passed on trailing historical metrics, though forward momentum in defense is high.
3. Valuation & Market Expectations
Valuation: Sunita Tools trades at 53.1x P/E, significantly above its peer median (18.8x). The market is already pricing in aggressive defense growth (e.g., target ₹636 Cr by FY29 announced in July 2026).
Promoter Holding: Dropped from 67.71% in Oct 2025 to 62.75% in Mar 2026, which warrants caution given rapid ambitious operational pivots.
4. Valuation Scenarios (24-36 Month Horizon)
Bull Case (+65% / ₹1,640): MoU converts to binding contract; Faridabad shell line scales to 1.3L+ units; drone JV bags domestic/GCC export contracts; FY28 EPS reaches ₹31 at 53x exit multiple.
Base Case (+20% / ₹1,195): Drone JV takes 2+ years to deliver initial orders; artillery shell execution proceeds as scheduled; FY28 EPS grows to ₹22 at 54x exit multiple.
Bear Case (-35% / ₹648): Non-binding MoU fails to materialize into firm orders; execution bottlenecks in artillery shell manufacturing; high capital intensity compresses cash flows; P/E re-rates down to 30x on FY28 EPS of ₹21.6.
5. Verdict Rationale
While Sunita Tools demonstrates aggressive strategic pivot into high-growth defense verticals, a non-binding MoU carries zero immediate contract value. High market valuation (53x P/E), promoter stake dilution, and execution risks across multiple new product lines cap the conviction at POSSIBLE with a LOW confidence (0.50) due to limited financial track record (< 8 quarters).
Analysis as of 2026-07-30 (price ₹996.20) ·
AI research, not investment advice.
· Expansion · Possible · Industrial Products · score 58/100
Deal
Deal value—
Deal vs businessQ1 FY27 revenue of ₹18.64 Cr represents ~24.5% of TTM revenue (₹76 Cr); 2 new machines added from COSMOS Machines
Size vs own revenue0.24×
Execution period3.0 yr
Fundamental gradeC
AI projections
Revenue uplift (yr1 / steady)20.0% / 150.0%
EPS uplift120.0%
Upside base / bull / bear40.0% / 110.0% / -35.0%
Horizon24-36 months
Realized market record
Entry — next-day open (27 Jul 2026)₹976.7
Latest close (16 Sep 2026)₹967.3
Return since-1.0%
α vs Smallcap 250-1.1%
Positives
Q1 FY27 net sales of ₹18.64 Cr confirms run-rate stability (~₹75 Cr annualized) relative to TTM revenue of ₹76 Cr
Addition of 2 large high-precision COSMOS machines expands capacity in higher-margin aerospace and precision engineering segments
Advancements in defence order execution evidenced by recent 1st advance tranche for NATO 155mm M107 shell contract
Structural tailwinds from Indian defence indigenization (Aatmanirbhar Bharat) and global demand for 155mm artillery shells
Risks
Base effect deception: The headline 350% YoY revenue jump is against an artificially depressed base of ₹4.14 Cr in Q1 FY26 and shows zero sequential expansion vs annualized TTM revenue
High execution and technological hurdles transitioning from basic mould/tooling manufacturing to NATO-standard explosive shell/fuse production
Sub-par historical ROCE (10.5%) combined with moderate balance sheet leverage (D/E 0.60, ₹43 Cr debt on ₹70 Cr net worth)
Promoter holding leakage from 67.71% in Oct 2025 to 62.75% in Mar 2026
Heavy reliance on a Middle East partner for order facilitation and MENA market access
Governance flags
Promoter holding decreased by nearly 5 percentage points (67.71% to 62.75%) between Oct 2025 and Mar 2026
Limited quarterly financial reporting history (fewer than 8 periods available)
On 2026-07-24, Sunita Tools Ltd announced a 350% YoY increase in Q1 FY27 consolidated net sales to ₹18.64 Cr (vs ₹4.14 Cr in Q1 FY26) alongside the commissioning of two new large-size high-precision machines from COSMOS Machines India for aerospace and precision engineering. While the YoY headline growth percentage appears spectacular, a rigorous analysis reveals that this is primarily driven by a severe base effect from Q1 FY26. The annualized Q1 FY27 revenue (~₹74.5 Cr) is virtually identical to the TTM revenue of ₹76 Cr. Nonetheless, the incremental machine additions support ongoing capacity buildout as the company transitions from legacy tooling to higher-value aerospace and defence manufacturing (155mm M107 shells).
1. Headline vs Operational Reality
YoY Growth Deconstruction: Q1 FY27 revenue of ₹18.64 Cr represents 24.5% of TTM revenue (₹76 Cr). The 350% YoY growth is relative to Q1 FY26 (₹4.14 Cr), which was an extraordinarily low quarter. On a run-rate basis, Q1 FY27 confirms that the business is maintaining its ~₹75-80 Cr top-line baseline, rather than stepping up exponentially in Q1.
Incremental Capacity Addition: The commissioning of two large COSMOS machines increases precision engineering capabilities for aerospace and legacy tooling, providing incremental throughput that supports management's FY27 targets prior to the full ramp-up of the Faridabad defence shell line.
2. Industry Context & Quality Gate Assessment
Industry Structure: Capital Goods / Precision Engineering moving into Defence Manufacturing.
Capital Intensity & Working Capital: HIGH. Precision tooling and defence manufacturing require heavy machinery capex, prolonged product qualification/testing cycles, and sizable working capital buffers for inventory/raw material sourcing.
Execution Difficulty: HIGH. Transitioning from mould bases and CNC precision parts to NATO-standard 155mm artillery shells involves strict quality standards, supply chain dependencies, and regulatory compliance.
Trailing Quality Metrics:
ROCE: 10.5% (Below the 15-20% standard quality gate benchmark)
Debt to Equity: 0.60 (₹43 Cr debt on ₹70 Cr Net Worth)
Trailing P/E: 49.1x (Peer median P/E is 19.1x)
Promoter Holding: Decreased from 67.71% (Oct 2025) to 62.75% (Mar 2026).
Quality Gate Verdict: FAILED on historical metrics. However, per evaluation rules, low trailing ROCE is treated as a key risk rather than an absolute veto given the credible catalyst of pivoting into high-margin defence manufacturing.
3. Ramp-Aware Catalyst Financial Math
Legacy & Aerospace Incremental Capacity: The 2 newly added COSMOS machines are expected to add ₹8-12 Cr in annualized revenue capacity once fully ramped over 12 months.
Defence Pivot Timeline:
Management targets ₹636 Cr revenue by FY29 (vs TTM ₹76 Cr), driven by expansion to 120k-130k artillery shell capacity.
Realistic Ramp: Defence shell lines require multi-stage trial runs, client certifications, and supply-chain stabilization. A realistic 3-year execution timeline assumes:
Bull Case (20% Probability): Flawless execution on the NATO 155mm shell contract, fast ramp-up of the 2 new COSMOS machines, successful forward integration into fuses/filled shells without regulatory delays.
Base Case (50% Probability): Moderate execution of legacy expansion and steady partial ramp of artillery shell manufacturing; normal working capital drag and minor technological bottlenecks.
Bear Case (30% Probability): Delivery delays, export restriction bottlenecks, working capital distress, and inability to achieve projected defence pricing power ($250-$300/piece).
Confidence: 0.45 (LOW due to <8 quarters of financial history, promoter stake dilution from 67.7% to 62.8%, and steep technological execution risk in artillery shell production).
Summary Rationale: Sunita Tools exhibits high operational option value through its strategic pivot into defence artillery manufacturing and incremental tooling expansions. However, the current stock price (₹920.4, 49.1x P/E) already prices in a significant portion of the near-term transition. The 350% YoY Q1 headline growth is distorted by base effects, and the business faces substantial execution risks, moderate leverage, and recent promoter stake reductions. The stock presents potential multibagger traits if defence execution hits bull-case guidance, but strict position sizing and monitoring of quarterly delivery execution are required.
Analysis as of 2026-07-24 (price ₹920.40) ·
AI research, not investment advice.
· Order win · Possible · Industrial Products · score 58/100
Deal
Deal value—
Deal vs businessOrder volume targets 477% growth (from 22.5k to 130k-210k units), implying steady-state revenue of ~₹300-500 Cr vs TTM of ₹76 Cr.
Execution period3.0 yr
Fundamental gradeC
AI projections
Revenue uplift (yr1 / steady)45.0% / 290.0%
EPS uplift310.0%
Upside base / bull / bear50.0% / 120.0% / -40.0%
Horizon24-36 months
Realized market record
Entry — next-day open (21 Jul 2026)₹902.4
Latest close (16 Sep 2026)₹967.3
Return since+7.2%
α vs Smallcap 250+8.5%
Positives
First advance tranche received, validating the contract and easing initial working capital pressure
Massive addressable market in NATO-standard 155mm artillery shells with high export potential
Strong revenue growth in the latest quarter (Mar 2026 revenue up 118% YoY to ₹31.18 Cr)
Strategic transition from low-margin tooling to high-margin defense precision components
Risks
High execution risk in transitioning from tooling to complex defense manufacturing
Promoter holding declined from 67.71% to 62.75% over the last 9 months
Extremely high valuation (P/E of 46.2 vs peer median of 20.9) leaves no room for execution delays
High capital intensity and debt (D/E of 0.60) could lead to equity dilution to fund the massive scale-up
Export restrictions or regulatory hurdles could block the 130,000-unit export target
Governance flags
Promoter holding decreased by ~5% (from 67.71% to 62.75%) within the last 9 months
High dependency on an undisclosed Middle East partner for order execution and facilitation
Full AI brief
1. Ramp-Aware Impact Math
Sunita Tools Ltd is attempting a massive pivot from a tooling manufacturer (TTM revenue of ₹76 Cr) to a defense player. The core of this thesis is the NATO-standard 155mm M107 empty artillery shell order.
Volume & Revenue Ramp: The company targets scaling production from 22,500 units in FY26 to a base case of 130,000 units (and best-case of 210,000 units) by FY28.
At an average price of USD 250 per piece in FY26, 22,500 units translates to ~$5.6M (approx. ₹47 Cr).
At an average price of USD 275 per piece (midpoint of USD 250-300) for the base-case 130,000 units by FY28, this translates to ~$35.75M (approx. ₹296 Cr at ₹83/USD). This represents a 290% steady-state revenue uplift over the TTM revenue of ₹76 Cr.
We assume a 3-year execution timeline (FY26 to FY29) to fully ramp up. Year 1 (FY27) revenue is projected to reach ₹110 Cr (a 45% uplift over TTM) as the first line in Faridabad stabilizes.
Earnings & Dilution Impact:
Management projects PAT margins between 16% and 20% for defense contracts. At an 18% steady-state PAT margin on ₹296 Cr revenue, steady-state PAT would be ₹53.3 Cr (compared to TTM PAT of ₹12 Cr).
However, scaling production by 477% requires significant capital expenditure and working capital. With a current D/E of 0.60 (Debt of ₹43 Cr on Net Worth of ₹70 Cr) and ROCE of only 10.5%, the company cannot fund this entirely through debt. We assume a 15% equity dilution to fund this expansion, increasing the share count from ~0.61 Cr to ~0.70 Cr.
Steady-state EPS (diluted) = ₹53.3 Cr / 0.70 Cr shares = ₹76.1 (a 305% uplift over TTM EPS of ₹18.76).
Valuation & Price Target:
The stock currently trades at a P/E of 46.2x, which is a massive premium to the peer median of 20.9x.
In the Base Case, as the company transitions to a defense player, the P/E is likely to compress to a more sustainable 25x. At 25x steady-state EPS of ₹76.1, the target price is ₹1,902, representing a 119% upside over 3 years (~30% CAGR). However, near-term valuation pressure and execution delays lead us to calibrate the immediate 12-24 month base-case upside to 50%.
2. Industry Capital Intensity & Expected CAGR
Capital Intensity: HIGH. Establishing automated forging, CNC machining, and testing lines for defense-grade artillery shells requires heavy upfront capex. The Faridabad facility is already being set up, but further scaling to 210,000 units will require continuous cash outflows.
Execution Difficulty: HIGH. Defense exports are highly regulated. Any quality rejection from NATO buyers or export license delays by Indian authorities could halt the entire ramp-up.
Industry CAGR: The Indian defense sector is growing at an 8% CAGR, but private sector defense manufacturing is projected to grow at a 25-40% CAGR, driven by the 'Aatmanirbhar Bharat' initiative and export incentives.
3. Multibagger Quality Assessment
Growth & Acceleration: Revenue is showing strong acceleration (Mar 2026 revenue of ₹31.18 Cr is up 118% YoY from Mar 2025). However, operating margins have fluctuated (OPM fell from 26.37% in FY25 to 22.2% TTM).
Balance Sheet & ROCE: Trailing ROCE is weak at 10.5%, reflecting the low-margin nature of the legacy tooling business. Debt is relatively high at ₹43 Cr.
Promoter Trend: A major red flag is the decline in promoter holding from 67.71% in October 2025 to 62.75% in March 2026. Promoter selling during a major growth pivot warrants extreme caution.
4. Scenario Analysis
Bull Case (120% Upside): Flawless execution of the Faridabad facility, reaching 210,000 units by FY28 at USD 300/piece. Revenue touches ₹500+ Cr with 20% PAT margins. P/E remains premium at 35x due to high growth.
Base Case (50% Upside): Reaching 130,000 units by FY29. Revenue touches ₹300 Cr, PAT margins stabilize at 17%, and P/E compresses to 25x.
Bear Case (-40% Downside): Export restrictions or technical bottlenecks halt the defense transition. Tooling business remains stagnant. The stock de-rates to the peer median P/E of 20x, dragging the price down to ~₹375.
5. Verdict Rationale
While the receipt of the first advance tranche validates the NATO order, the stock is already pricing in a significant portion of this transition (trading at 46.2x P/E, with the pivot detailed in the July 8 investor presentation). Given the low trailing ROCE, recent promoter selling, and high capital intensity, we classify Sunita Tools as a POSSIBLE multibagger rather than a strong candidate, pending concrete revenue execution from the defense division.
Analysis as of 2026-07-20 (price ₹867.45) ·
AI research, not investment advice.
Deal vs businessTarget FY29 revenue of 636 Cr is 8.3x TTM revenue of 76 Cr.
Size vs own revenue8.30× — oversized — in the 90-day study 20% of these fell >25%, against 4% of deals under half of revenue
Execution period3.0 yr
Fundamental gradeC
AI projections
Revenue uplift (yr1 / steady)45.0% / 320.0%
EPS uplift246.0%
Upside base / bull / bear106.0% / 360.0% / -60.0%
Horizon36 months
Realized market record
Entry — next-day open (09 Jul 2026)₹801.8
Latest close (16 Sep 2026)₹967.3
Return since+20.6%
α vs Smallcap 250+21.6%
Positives
Massive capacity creation with Line 1 (1.2L shells) and planned Line 2 (2.4L shells).
Strategic acquisition of NMI in the US provides immediate geographic diversification and a large grease cartridge capacity.
Pivoting into a high-margin, high-multiple sector (Defence) from low-margin tooling.
Strong tailwinds from 'Aatmanirbhar Bharat' and rising private sector share in Indian defence.
Risks
DPIIT license for the Faridabad facility is still pending; production cannot start without it.
High execution risk transitioning from a tooling manufacturer to a high-precision defence player.
Significant dependency on a Middle East partner for executing M107 orders.
Potential equity dilution to fund the massive capital expenditure and working capital requirements.
Governance flags
Promoter holding decreased from 67.71% in Oct 2025 to 62.75% in Mar 2026.
Full AI brief
Executive Summary
Sunita Tools Ltd is attempting a high-stakes pivot from a micro-cap precision tooling manufacturer (TTM Revenue: 76 Cr) into a high-growth defence player targeting 636 Cr in revenue by FY29. While the capacity additions (Line 1 installed, Line 2 planned) and the US acquisition of New Mould Innovations (NMI) are highly ambitious, execution risks are substantial. The company currently lacks a DPIIT license for its defence facility, and promoter holding has recently declined by ~5%. We classify this as a high-risk, high-reward 'POSSIBLE' multibagger candidate.
Ramp-Aware Impact Math
Baseline: TTM Revenue is 76 Cr, TTM PAT is 12 Cr, and TTM EPS is 18.76. Current share count is ~0.615 Cr shares.
Year 1 (FY27) Outlook: We assume a conservative 45% revenue uplift ( 110 Cr) because the DPIIT license is still pending, which will delay the commercial ramp-up of the Faridabad defence facility. NMI consolidation will provide some cushion.
Steady-State (FY29) Base Case: Management targets 636 Cr revenue and 102 Cr PAT. Applying a 50% haircut for execution delays, export hurdles, and licensing bottlenecks, we project a realistic Base Case FY29 Revenue of 320 Cr (320% uplift). At a 15% PAT margin (lower than management's 16-20% due to initial inefficiencies), PAT would reach 48 Cr. Assuming 20% equity dilution to fund capex, the share count rises to 0.74 Cr, yielding an EPS of 65 (246% uplift).
Industry Capital Intensity & CAGR
The defence manufacturing sector is highly capital-intensive, requiring specialized machinery, testing facilities, and long working capital cycles. While the overall Indian defence sector is growing at an 8% CAGR, the private sector contribution is growing at 25-40% CAGR due to import substitution ('Aatmanirbhar Bharat').
Valuation & Scenario Analysis
Base Case (Target Price: 1,625 | Upside: 106%): Assumes successful DPIIT licensing by H2 FY27, moderate ramp-up of shell production, and a conservative 25x P/E multiple (re-rated from peer median of 21.6x due to defence mix, but lower than current 41.9x due to scale maturation).
Bull Case (Target Price: 3,630 | Upside: 360%): Assumes management achieves 80% of their FY29 targets ( 500 Cr revenue, 18% PAT margin, 121 EPS) and commands a premium 30x P/E multiple.
Bear Case (Target Price: 320 | Downside: -60%): Assumes DPIIT license is indefinitely delayed, the US acquisition underperforms, and the company remains largely a tooling player with diluted equity. P/E de-rates to 20x on 16 EPS.
Verdict Rationale
The massive scale of the pivot makes Sunita Tools an intriguing micro-cap. However, the lack of a current DPIIT license, low trailing ROCE (10.5%), and recent promoter selling prevent a 'STRONG_CANDIDATE' rating. Execution over the next 12-18 months is critical.
Analysis as of 2026-07-08 (price ₹786.10) ·
AI research, not investment advice.
Verdicts and projections on this page are produced by an AI model from Sunita Tools Ltd's public exchange
filings and are not investment advice. "Return since" is measured from the opening price
of the next trading day after each announcement to the latest available close, so it reflects a price an
investor could actually have paid. See all analysed companies on
Multibagger AI.
⚠️How this site is made: Market data pages are computed automatically from NSE/BSE publications and company filings; news articles and announcement analyses are written with AI assistance, with a human in the loop: our editors review what the AI produces. Both can contain errors. Verify with the original sources before any investment decision. Not investment advice; Flash Finance is not SEBI-registered. How we use AI
⚡ Free FlashFinance Newsletters
AI-powered market intelligence in your inbox — completely free. Pick your topics; max 1 email per topic per day. Unsubscribe anytime.
✅ Everything below is 100% free — no payment, no card, ever.
🎉
You're subscribed!
A welcome email with your topics is on its way. Want it even faster? Join us on Telegram or WhatsApp: